ACORQ — Acorda Therapeutics Share News
0.000.00%
Last trade - 00:00- $0.02m
- $182.13m
- $117.63m
Brief: Acorda Therapeutics And Chance Pharmaceuticals Announce Agreement To Commercialize Inbrija In China
U.S. STOCKS ON THE MOVE-BioNTech, Tupperware Brands, Tyson Foods
Acorda Therapeutics up on agreement to commercialize Parkinson's drug in China
Brief: Acorda Therapeutics Inc - As Of March 13, Had About $8.3 Million On Deposit With Svb
Brief: Acorda Therapeutics Inc Reports Quarterly Net Income Per Common Share Diluted Of $0.57
Brief: Acorda Therapeutics Receives Nasdaq Extension To Meet Minimum Bid Price Requirement
Brief: Acorda Therapeutics - On Dec 31, 2022, Entered New Msa With Catalent Massachusetts Llc, Terminated Prior Manufacturing Services Agreement, Dated Feb 10, 2021
Brief: Acorda Therapeutics Announces New Agreement With Catalent For Long-Term Global Supply Of Inbrija®
Brief: Acorda Therapeutics Announces Revised Long-Term Financial Guidance
Brief: Acorda Therapeutics Receives Nasdaq Listing Determination Letter And Plans To Request A Hearing
Brief: Acorda Therapeutics Announces Adjournment Of Special Meeting Of Stockholders
Brief: Acorda Therapeutics Reports Third Quarter 2022 Financial Results
Brief: Acorda Therapeutics Provides Long-Term Business Plan And Financial Guidance
Brief: Iss, Glass Lewis, And Egan-Jones Recommend That Acorda Stockholders Vote For The Proposal To Implement A Reverse Stock Split
U.S. STOCKS ON THE MOVE-Alvotech, Verizon, Lyft, BofA
U.S. STOCKS ON THE MOVE-Gold miners, Protera, Sorrento
U.S. STOCKS ON THE MOVE-Bank of America, Archaea, Roblox
U.S. STOCKS ON THE MOVE-Splunk, Bank of America, Acorda
Acorda gains as arbitration panel awards $16.5 million from Alkermes